Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Kiora Pharmaceuticals Inc KPRX

Healthcare
Kiora Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of orphan retinal diseases. Its pipeline consists of three product candidates, including KIO-301, KIO-104, KIO-101 and KIO-201. Its lead product, KIO-301, is a vision-restoring small molecule that is designed to restore vision in patients... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:KPRX)

Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study

Newsfile 7 days ago

Kiora Pharmaceuticals to Present at Upcoming Investor Conferences

Newsfile 13 days ago

Kiora Pharmaceuticals to Present Additional Data from Its ABACUS-1 Trial in Retinitis Pigmentosa at the ARVO 2024 Annual Meeting

Newsfile March 28, 2024

Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases

Newsfile March 25, 2024

Kiora Announces Publication of Phase 1 Study Demonstrating Safety, Tolerability and Anti-Inflammatory Activity of KIO-101 in the Treatment of Inflammation of the Eye

Newsfile March 8, 2024

Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million

Newsfile January 31, 2024

Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement to Develop and Commercialize KIO-301 for the Treatment of Inherited Retinal Diseases; Total Deal Value of up to $301 Million includes $16 Million Upfront, up to $285 Million in Clinical Development, Regulatory and Commercial Milestones, Plus Commercial Royalties

Newsfile January 31, 2024

Kiora Pharmaceuticals Reports Q3 2023 Results; Expanding Clinical Development of KIO-301 for Inherited Retinal Diseases Based on Encouraging Results of ABACUS-1 Study in Retinitis Pigmentosa

Newsfile November 9, 2023

AAO Late-Breaking: Kiora's Small Molecule Photoswitch Demonstrates Meaningful Vision Improvements in Blind Patients with Retinitis Pigmentosa

Newsfile November 4, 2023
View More News ››

Opinion & Analysis (NDAQ:KPRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:KPRX)

5 Value Stocks To Watch In The Healthcare Sector | Benzinga

Breaking News: $KPRX 5 Value Stocks To Watch In The Healthcare Sector | BenzingaWhat Defines a Value Stock?A value stock is...
whytestocks - February 5, 2024

What's Going On With Kiora Pharmaceuticals Stock? | Benzinga

Just In: $KPRX What's Going On With Kiora Pharmaceuticals Stock? | BenzingaKiora Pharmaceuticals, Inc. (NASDAQ:KPRX) shares are...
whytestocks - February 1, 2024

Kiora Pharmaceuticals to Present at Upcoming Investor Confer

NEWS: $KPRX Kiora Pharmaceuticals to Present at Upcoming Investor ConferencesEncinitas, California--(Newsfile Corp. - June 14, 2023...
whytestocks - June 14, 2023

KPRX.....this has been all over the map this a.m ; )

This is what these "thinners" do Just an observation No position.....yet ; )  Cheers !
Iseneschal - February 17, 2023

KPRX.....Bouncing off the low diring PM trading... $7.79

Ya never know  Me no position Ski day ; )
Iseneschal - February 9, 2023

KPRX ....I hope that alert save a few

Lets see what happens during AH Me no position....Made some real good coin on this today Still standing to fight another day...
Iseneschal - February 8, 2023
View more Bullboard ››

Acceleware Ltd

Acceleware Ltd

Acceleware Ltd. is a Canada-based company that develops clean-tech decarbonization technologies. The Company has two business ...
View More »